Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

ClinicalTrials.gov ID: NCT06701526

Public ClinicalTrials.gov record NCT06701526. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Open-label Trial, Investigating the Effectiveness of Eptinezumab in Participants With Migraine and Previous Inadequate Response to CGRP-targeting Therapies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).

Study identification

NCT ID
NCT06701526
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
164 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2024 (Actual)
Primary completion
Sep 2, 2026 (Actual)
Completion
Sep 2, 2026 (Actual)
Last update posted
Sep 9, 2026

2024 – 2026

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
St. Joseph's Hospital and Medical Center-Barrow Neurological Institute - Barrow Brain Tumor Resea... Phoenix Arizona 85013-4409 —
Mayo Clinic - Vascular Center - Arizona Phoenix Arizona 85054-4502 —
Baptist Health Center for Clinical Research (BHCCR) Little Rock Arkansas 72205-6355 —
The Neuron Clinic - Escondido San Marcos California 92069 —
Sunwise Clinical Research, LLC Walnut Creek California 94549-4500 —
Hasbani Neurology - New Haven New Haven Connecticut 06511 —
New England Institute for Neurology and Headache (NEINH) - Stamford Stamford Connecticut 06905 —
Brainstorm Research, Inc. Miami Florida 33176 —
Chicago Headache Center and Research Institute - Chicago Chicago Illinois 60657-9269 —
Crescent City Headache and Neurology Center Chalmette Louisiana 70043-1668 —
Neurology Center of New England, PC Foxborough Massachusetts 02035 —
Mass Institute of Clinical Research Westborough Massachusetts 01581 —
Michigan Headache & Neurological Institute (MHNI) Ann Arbor Michigan 48104-5131 —
Albany Medical College Albany New York 12208-3412 —
Dent Neurosciences Research Center Amherst New York 14226-1727 —
North Suffolk Neurology - Port Jefferson Station Port Jefferson Station New York 11776 —
Headache Wellness Center Greensboro North Carolina 27405-6962 —
C7 Research Cleveland Ohio 44109 —
Thomas Jefferson University Hospital - Breast Care Center Philadelphia Pennsylvania 19107-5563 —
Preferred Primary Care Physicians - Pleasant Hills - Curry Hollow Road Pittsburgh Pennsylvania 15236-4604 —
KCA Neurology, PLLC Franklin Tennessee 37067 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06701526, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06701526 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →